drugset / Trial / NCT00878540

Short-term Metabolic Effects of Mirtazapine in Healthy Subjects

NCT00878540

Phase 1 Completed 12 enrolled Max-Planck-Institute of Psychiatry
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to determine metabolic changes upon a 7 day medication of 30 mg mirtazapine per day in healthy subjects.

Timeline

Start
2008-09
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirtazapine Other / unclassified 30 mg

Indications

No indication recorded.